Kodiak gains as Barclays upgrades on Roche data for eye disease drug
Source: SeekingAlpha
2025-09-25 10:35:17 ET
More on Kodiak Sciences
- Kodiak Sciences: Odds May Be Narrowing For Longer Lasting Eye Disease Med Approval
- Seeking Alpha’s Quant Rating on Kodiak Sciences
- Historical earnings data for Kodiak Sciences
- Financial information for Kodiak Sciences
Read the full article on Seeking Alpha
For further details see:
Kodiak gains as Barclays upgrades on Roche data for eye disease drug
Roche Holding Ltd
NASDAQ: RHHBF
RHHBF Trading
-6.23% G/L:
$436.044 Last:
31 Volume:
$411.36 Open:
RHHBF Latest News
RHHBF Stock Data
$362,551,633,888
800,578,845
N/A
474
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
